(Q48405092)

11 February 2018

title

Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients (English)

1 reference

11 February 2018

1 reference

Rosa Maria Moresco

1

1 reference

11 February 2018

Lucia Pietra

2

1 reference

11 February 2018

Marta Henin

3

1 reference

11 February 2018

Andrea Panzacchi

4

1 reference

11 February 2018

Marco Locatelli

5

1 reference

11 February 2018

Lorena Bonaldi

6

1 reference

11 February 2018

Assunta Carpinelli

7

1 reference

11 February 2018

Clara Gobbo

8

1 reference

11 February 2018

Laura Bellodi

9

1 reference

11 February 2018

Daniela Perani

10

1 reference

11 February 2018

Ferruccio Fazio

11

1 reference

11 February 2018

language of work or name

English

0 references

publication date

4 October 2006

1 reference

11 February 2018

published in

Neuropsychopharmacology

1 reference

11 February 2018

volume

32

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

197-205

1 reference

11 February 2018

Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Multimodal image coregistration and partitioning--a unified framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Treatment of late-onset OCD following basal ganglia infarct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

“Dopamine-Dependent” Side Effects of Selective Serotonin Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

PET Studies of the Effect of the Antidepressant Drugs Nefazodone or Paroxetine on [11C]Raclopride Binding in Human Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Dopamine transporter density of basal ganglia assessed with [ 123 I]IPT SPET in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Evidence for striatal dopamine release during a video game

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Comparison of methods for analysis of clinical [11C]raclopride studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Assessment of spatial normalization of PET ligand images using ligand-specific templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Animal models of compulsive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Cocaine addiction: hypothesis derived from imaging studies with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

7 January 2021

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

7 January 2021

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

7 January 2021

The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

7 January 2021

Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

7 January 2021

Bilateral anterior capsulotomy for refractory obsessive-compulsive disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

7 January 2021

Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301199

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301199

1 reference

11 February 2018

1 reference

11 February 2018